Введение лекарственных препаратов в субтеноновое пространство глаза в лечении передней ишемической нейропатии

Сакович, В.Н. and Гречка, Е.М. and Степахина, М.Э. and Дербина, Е.А. and Гузенко, Н.В. (2017) Введение лекарственных препаратов в субтеноновое пространство глаза в лечении передней ишемической нейропатии. Медичні перспективи, Т. 22 (№ 1). pp. 50-54. ISSN 2307-0404

[img]
Preview
Text
Med_persp_17_22_1_50-54.pdf

Download (251kB) | Preview
Official URL: http://medpers.dsma.dp.ua/

Abstract

In spite of treatment provided inanterior ischemic neuropathy, a prognosis for visual functions is poor and depends on severity of affection ofvascular system of the body. We have studied the exposure to cortexin and diprospan in subtenon administration on the eye hemodynamics in 18 patients experiencing anterior ischemic neuropathy(18 eyes) who have been treated operatively (administration of cortexin and diprospan into the subtenon space of the affected eye) against the background of complex conservative prevention. The control group was constituted of 16 patients (16 eyes) who have not been treated operatively. As a result of provided treatment the patients of the basic group showed increase of vision acuity, field of view limits and eye ground state.

Item Type: Article
Additional Information: DOI: https://doi.org/10.26641/2307-0404.2017.1.100899
Uncontrolled Keywords: anterior ischemic neuropathy; subtenon eye space; treatment; передняя ишемическая нейропатия; субтеноновое пространство; лечение.
Subjects: Ophthalmology
Clinical medicine
Divisions: Departments > Department of Neurology
Depositing User: Елена Шрамко
Date Deposited: 10 May 2018 12:47
Last Modified: 10 May 2018 12:47
URI: http://repo.dma.dp.ua/id/eprint/2739

Actions (login required)

View Item View Item